Perfuze shares “strong reperfusion and first-pass performance” in final MARRS trial publication
Perfuze has announced the publication of the final results of the MARRS pivotal study in the Journal of NeuroInterventional Surgery (JNIS). The trial met its...
Basking Biosciences announces positive topline phase-one data on BB-025 reversal agent
Basking Biosciences has announced positive topline data from its phase-one study of BB-025, an investigational, rapid-acting reversal agent designed to specifically bind to and...
Philips selected to advance AI-enabled robotic stroke care via ARPA-H programme
Royal Philips has today announced it has received an award of up to US$33.7 million under the Advanced Research Projects Agency for Health (ARPA-H)—an agency...
